Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan - Takeuchi, T; Tanaka, Y; Tanaka, S (Ann Rheum Dis, 2019)